FASN and infection: DENV-2 replication was reduced by the treatment of cells with FASN-specific siRNA, cerulenin, or C75, and Orlistat treatment significantly reduced infection and virion production of a lab-adapted DENV-4 strain and clinical hemorrhagic fever DENV-4 isolate (13, –, 15).